-
Study aim
-
The effect of laser therapy on pulmonary function and inflammatory factors in patients with Covid 19 in the acute phase of the disease
-
Design
-
َA randomized controlled double-blind clinical trial with parallel groups. Phase 3 on 30 patients. A random table of numbers will be used for randomization.
-
Settings and conduct
-
This research will be conducted in Kosar Hospital of Semnan University of Medical Sciences. After enrollment in the study, patients will be randomly assigned into active and sham-laser groups and then in the intervention group, patients will be intervened with 5 sessions of high power laser. In both groups, standard treatments include non-invasive ventilation, antibiotics (oral and injectable if needed), supportive vasopressor, artificial kidney, and extracellular membrane oxygenation. In the control group, standard treatment with sham-laser will be performed on the same points.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria included individuals with COVID-19 with a positive PCR test who will be hospitalized due to severe pulmonary involvement. Patients who inevitably undergone to use invasive ventilation or if there is a contraindication for laser treatment will also excluded from the study.
-
Intervention groups
-
The first group includes active laser in which the laser will be applied for 5 daily sessions. In the control group, exactly the same method, but when the device set is off , the probe will move. The laser protocol including C.P.S waves, will be used for 30 minutes (15 minutes on each side) at 650 and 905 nm to reduce pneumonia.
-
Main outcome variables
-
Pneumonia severity indices, and laboratory tests including O2 saturation (SaO2), inflamatory factors including Lymph percentage, Neutrophil / Lymphocyte ratio, Interleukin-6, Ferritin, Erythrocyte sedimentation ratio، low density lipoprotein, C-Reactive protein.